You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Details for New Drug Application (NDA): 021253

✉ Email this page to a colleague

NDA 021253 describes ZYPREXA, which is a drug marketed by Cheplapharm and is included in four NDAs. It is available from two suppliers. Additional details are available on the ZYPREXA profile page.

The generic ingredient in ZYPREXA is olanzapine pamoate. There are thirty-three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the olanzapine pamoate profile page.

Summary for 021253

Tradename:	ZYPREXA
Applicant:	Cheplapharm
Ingredient:	olanzapine
Patents:	0

Pharmacology for NDA: 021253

Suppliers and Packaging for NDA: 021253

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
ZYPREXA	olanzapine	INJECTABLE;INTRAMUSCULAR	021253	NDA	Eli Lilly and Company	0002-7597	0002-7597-01	1 VIAL in 1 CARTON (0002-7597-01) / 2 mL in 1 VIAL
ZYPREXA	olanzapine	INJECTABLE;INTRAMUSCULAR	021253	NDA	H2-Pharma LLC	61269-640	61269-640-20	1 VIAL in 1 CARTON (61269-640-20) / 2 mL in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INTRAMUSCULAR			Strength	10MG/VIAL
Approval Date:	Mar 29, 2004	TE:	AP	RLD:	Yes

Expired US Patents for NDA 021253

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Cheplapharm	ZYPREXA	olanzapine	INJECTABLE;INTRAMUSCULAR	021253-001	Mar 29, 2004	⤷ Get Started Free	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.